A Population-Based Clinical Trial of Irinotecan and Carboplatin

<table>Distribution
of individual dose levels associated with dose-limiting toxicity (DLT) of irinotecan
and carboplatin (<i>N</i> = 50).</table>

Journal of Oncology

Figure 1: A Population-Based Clinical Trial of Irinotecan and Carboplatin 